Hot study: Quality of the blood pressure control after 2 years follow- up;Etude hot: Qualite du controle tensionnel apres 2 ans de suivi des patients

Archives des Maladies du Coeur et des Vaisseaux

Volumn 90, Issue 8, 1997, Pages 1175-1179

  Herpin, D ^a   Mallion, J M ^b   Dahan, R ^c   Benkritly, A ^c   Boutelant, S ^b   Baguet, J P ^b   Noir Clerc, M ^b  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c Laboratoires ASTRA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; FELODIPINE;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FRANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; BLOOD PRESSURE; CLINICAL TRIAL; DRUG COMBINATION; EUROPE; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; RISK FACTORS;

EID: 0030793829     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Hansson L for the HOT study group. The hypertension optimal treatment study. Blood Pressure 1993 ; 2 : 62-8.
2. Hansson L, Zanchetti A for the HOT study group. The hypertension optimal treatment (HOT) study. Patient characteristics : randomization, risk profiles and early blood pressure results. Blood Pressure 1994 ; 3 : 322-7.
3. Hansson L, Zanchetti A for the HOT study group. The hypertension optimal treatment (HOT) study ; 12-month data on blood pressure and tolerability with special reference to age and gender. Blood Pressure 1995 ; 4 : 313-9.
4. Chatellier G, Degoulet P Devries C, Vu HA, Plouin PF, Ménard J. Symptom prevalence in hypertensive patients. Eur Heart J 1982 ; 3 (suppl C) : 45-52.
5. Hansson L The BBB study : effect of intensified antihypertenseur treatment on the level of blood pressure, side effects, morbidity and mortality in "well-treated" hypertensive patients. Blood Pressure 1995 ; 3 : 328-54.